ArticleFrontiers of medicine2021

Long-term results of suppressing thyroid-stimulating hormone during radiotherapy to prevent primary hypothyroidism in medulloblastoma/PNET and Hodgkin lymphoma: a prospective cohort study.

Maura Massimino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.